Emc Capital Management Mei Pharma, Inc. Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $51,500 - $261,319	-95,372 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$2.6 - $3.65 $11,346 - $15,928	4,364 Added 4.8%	95,372 $272,000
Q1 2021 May 05, 2021	BUY	$2.73 - $4.5 $71,886 - $118,494	26,332 Added 40.71%	91,008 $312,000
Q4 2020 Feb 24, 2021	BUY	$2.6 - $3.32 $168,157 - $214,724	64,676 New	64,676 $171,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $333M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.